Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib)..
Investigational chemotherapy-free regimen of amivantamab plus lazertinib addresses a significant unmet need as most patients with..